United States · FDA National Drug Code directory
Eslicarbazepine Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68180-292_2c3d221b-f0d3-4845-8bbc-9a4df2f0cc33
- Product NDC
- 68180-292
- Form
- TABLET
- Composition / generic term
- Eslicarbazepine Acetate
- Labeler
- Lupin Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250506
- Source listing expiry
- 20261231
Source-listed ingredients
- ESLICARBAZEPINE ACETATE — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (68180-292-07) · 68180-292-07
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →